Confidentiality concerns are a well-established barrier to sexual health services for adolescents. These barriers are likely even greater for young men who have sex with men (YMSM), who often experience stigma at multiple levels. This study examined the relationship between state laws regulating minors' access to confidential sexual health services, sexual behavior, and lifetime HIV testing among a large, representative sample of sexually active male high school students from the 2019 state-level Youth Risk Behavior Surveillance System (23 states; N = 17,509). We used multilevel logistic regression to examine whether confidentiality-promoting state laws (i.e., states that explicitly allowed minors to self-consent to HIV testing, did not have an age clause which set a minimum age to self-consent to sexual health services, did not permit parental notification, had confidentiality protections for insured dependents) were associated with lifetime HIV testing, and whether associations differed between YMSM (n = 1,718) and young men who have sex with women only (i.e., YMSWO; n = 15,791). After adjusting for individual- and state-level characteristics, HIV testing was significantly more likely for students in states that explicitly allowed minors to self-consent to HIV testing (adjusted odds ratio [aOR]: 1.12, 95% confidence interval [CI]: 1.05-1.21, p <.001), did not permit parental notification (aOR: 1.09, CI: 1.05-1.12, p <.001), or had confidentiality protections for insured dependents (aOR: 1.40, CI: 1.34-1.45, p <.001), and significantly less likely for those in states that lacked age clauses (aOR: 0.82, CI: 0.80-0.84, p <.001). We found no evidence for moderation of these associations by YMSM status (i.e., the effects of laws being confidentiality-promoting on HIV testing did not differ significantly for YMSM and YMSWO). Findings suggest that certain confidentiality-promoting state laws may be effective at increasing HIV testing among sexually active male adolescents, regardless of sexual behavior.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10461-024-04574-xDOI Listing

Publication Analysis

Top Keywords

hiv testing
24
sexual health
16
health services
16
state laws
12
lifetime hiv
12
laws regulating
8
regulating minors'
8
minors' access
8
access confidential
8
confidential sexual
8

Similar Publications

Background: Accurate assessment of cognitive impairment in low-income settings may require consideration of complex psychosocial variables (PV). Failure to consider the association of PV with biological factors, such as HIV, could lead to false classification of cognitive impairment. We investigated the impact of PV on cognitive performance in people with HIV (PWH) and without in a low-income area of Cape Town, South Africa.

View Article and Find Full Text PDF

People living with HIV (PLWH) are disproportionately affected by depression, which often remains underdiagnosed and untreated, negatively impacting quality of life and treatment outcomes. Low resource settings often lack clinical professionals to identify depression, therefore screening tools such as the PHQ-9 allow for broader depression screening. This qualitative study among PLWH in Yaoundé Cameroon aimed to a) explore local understandings of depression and mental distress and b) assess comprehension and interpretation of the PHQ-9 items and response categories.

View Article and Find Full Text PDF

Monitoring for advanced disease in the universal test and treat era: trends in CD4 count testing in South Africa.

BMC Glob Public Health

January 2025

Health Economics and Epidemiology Research Office, Department of Internal Medicine, Faculty of Health Sciences, School of Clinical Medicine, University of the Witwatersrand, Johannesburg, South Africa.

Background: Under South Africa's Universal Test and Treat (UTT) policy, CD4 counts are no longer required to determine HIV treatment eligibility. However, CD4 count at presentation remains an important marker of disease progression. We assessed whether CD4 testing declined in the UTT era and, if so, by how much.

View Article and Find Full Text PDF

Introduction: Long-acting injectable cabotegravir (CAB-LA) for pre-exposure prophylaxis significantly reduced HIV acquisition in HPTN 084. We report on the safety and CAB-LA pharmacokinetics in pregnant women during the blinded period of HPTN 084.

Methods: Participants were randomized 1:1 to either active cabotegravir (CAB) plus tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) placebo or active TDF/FTC plus CAB placebo.

View Article and Find Full Text PDF

Data on the HIV care cascade demonstrated challenges in achieving Ending the HIV Epidemic (EHE) targets across all 18 EHE focus metropolitan areas, but innovative adherence interventions using point-of-care tenofovir testing and motivational interviewing support care cascade outcomes in Namibia and South Africa, respectively. Data on treatment with long-acting injectable (LAI) antiretroviral therapy (ART) demonstrated high acceptability, retention, and virologic suppression including in groups that were not well represented in clinical trials including persons born female and persons with detectable viral loads. The adjuvanted hepatitis B vaccine appeared to be safe and appeared to be superior to conventional hepatitis B vaccines in persons with HIV (PWH) who were prior nonresponders to the hepatitis B vaccine.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!